Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1384)	12/30/1997 12:32:00 AM
From: Bruce Rosen	Read Replies (4) \| Respond to of 7041

Questions of dubious relevance with no answers provided: <<Want to talk about the fact that the parallel study was unblinded with an 80mg test dose being given to each study participant? Want to discuss the fact that before the participants were randomized in the study they knew what it was like to have a double dose?>> You bring this up, but make no logical point. <<Want to discuss the fact that one of the AEs (adverse events) was a heart attack?>> When and where? Under what circumstances? This is a new unsubstantiated assertion. As far as I know, there were only two serious adverse events out of thousands of administrations of Vasomax, both at the 80 mg dosages. Neither was a heart attack. The actual dosage will be 40 mg, at which no serious side effects were reported. <<Want to talk about the fact that Pfizer spent over $400 million on Viagra and that Schering's $10 million bet is a drop in the bucket...not to mention that Schering has a failed history of making winners out of orphan drugs.>> Talk all you want about this. Zonagen has spent many millions on developing this and Schering's up front committment is $57.5 million, upon attainment of milestones. Schering has been the best performing major pharma stock of 1997. Sounds like a pretty successful history to me. They did their due diligence, including analyzing the structure of the clinical trials and their results. They made a sizable financial committment to attain marketing rights to this potential blockbuster drug. <<Want to speculate about the possibility that certain people associated with the company and with Raymond James may be so appalled with this fraud that they have chosen to tell the public what's really going on?>> Huh? Is this your latest plunge into your cyber-fantasyland?